Alpha 2.0
Login Register
» Authors » Nishant Agrawal

Nishant Agrawal

Explore the profile of Nishant Agrawal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 167
Citations 10464
Followers 0
Related Specialties
Oncology
General Surgery
Otorhinolaryngology
Top 10 Co-Authors
Evgeny Izumchenko
Chetan Bettegowda
Bert Vogelstein
Kenneth W Kinzler
Zhen Gooi
Ari J Rosenberg
Alexander T Pearson
Nickolas Papadopoulos
Everett E Vokes
Carole Fakhry
Published In
Head Neck
Oral Oncol
Otolaryngol Head Neck Surg
JAMA Otolaryngol Head Neck Surg
Proc Natl Acad Sci U S A
Affiliations
Soon will be listed here.
Recent Articles
1.
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial
Rosenberg A, Juloori A, Jelinek M, Agrawal N, Cursio J, Cipriani N, et al.
JAMA Oncol . 2025 Mar; PMID: 40048190
Importance: Neoadjuvant immunotherapy in human papillomavirus (HPV)-negative locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) appears promising, yet its role in nonsurgical treatment for head and neck cancer...
2.
Effects of ex vivo machine perfusion on preservation time and donor age in donation after brain death heart transplantation
Hong Y, Hess N, Ziegler L, Dorken-Gallastegi A, Abdullah M, Agrawal N, et al.
J Heart Lung Transplant . 2025 Mar; PMID: 40047739
With encouraging early experience, ex vivo machine perfusion (MP) systems are increasingly employed in heart transplantation. In this study, utilizing a national registry database, 2 separate analyses were performed to...
3.
Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas
Hieromnimon H, Trzcinska A, Wen F, Howard F, Dolezal J, Dyer E, et al.
Oral Oncol . 2025 Mar; 163:107207. PMID: 40043423
Objectives: Human papillomavirus (HPV) influences the pathobiology of Head and Neck Squamous Cell Carcinomas (HSNCCs). While deep learning shows promise in detecting HPV from hematoxylin and eosin (H&E) stained slides,...
4.
Circulating tumor DNA in head and neck squamous cell carcinoma-current status and future prospects
Auger S, Mishra V, Singh A, Miao Y, Agrawal N, Izumchenko E
Acad Oncol . 2025 Jan; 1(2). PMID: 39867572
Squamous cell carcinoma (SCC) is the most common malignancy of the head and neck. Stagnating survival rates in recent decades, despite advances in the treatment paradigms, surveillance technologies, and multidisciplinary...
5.
PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands
Mishra V, Singh A, Korzinkin M, Cheng X, Wing C, Sarkisova V, et al.
J Exp Clin Cancer Res . 2025 Jan; 44(1):11. PMID: 39794830
Background: Adenoid cystic carcinoma (ACC) is a rare glandular malignancy, commonly originating in salivary glands of the head and neck. Given its protracted growth, ACC is usually diagnosed in advanced...
6.
Extended aortic coverage in thoracic aortic endovascular repair is not associated with spinal cord ischemia
Chachati G, Yousef S, Brown J, Agrawal N, Tarun S, Punu K, et al.
JTCVS Open . 2024 Nov; 21:366-371. PMID: 39534332
Objective: Spinal cord ischemia (SCI) after thoracic endovascular aortic repair (TEVAR) remains a debilitating complication, occurring in 10% of patients. Studies have shown that extended aortic coverage is a risk...
7.
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors
Golbourn B, Ho B, Bondoc A, Luck A, Fan X, Richardson E, et al.
Neuro Oncol . 2024 Jul; 26(10):1895-1911. PMID: 38981018
Background: Atypical teratoid rhabdoid tumor (ATRT) is a rare, devastating, and largely incurable pediatric brain tumor. Although recent studies have uncovered 3 molecular subgroups of ATRTs with distinct disease patterns,...
8.
Long-term outcomes of total arch replacement with bilateral antegrade cerebral perfusion using the "arch first" approach
Brown J, Yousef S, Serna-Gallegos D, Sa M, Agrawal N, Thoma F, et al.
Perfusion . 2024 Jun; :2676591241259622. PMID: 38863259
Objective: To report outcomes of total arch replacement (TAR) with hypothermic circulatory arrest and bilateral antegrade cerebral perfusion (bACP) using an "arch first" approach for acute Type A aortic dissection...
9.
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial
Rosenberg A, Agrawal N, Juloori A, Cursio J, Gooi Z, Blair E, et al.
JAMA Oncol . 2024 Jun; 10(7):923-931. PMID: 38842838
Importance: Immune checkpoint inhibitors improve survival in recurrent and/or metastatic head and neck cancer, yet their role in curative human papillomavirus-positive oropharyngeal cancer (HPV+ OPC) remains undefined. Neoadjuvant nivolumab and...
10.
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
Cyberski T, Singh A, Korzinkin M, Mishra V, Pun F, Shen L, et al.
NPJ Precis Oncol . 2024 May; 8(1):114. PMID: 38783041
The proto-oncogene MYC encodes a nuclear transcription factor that has an important role in a variety of cellular processes, such as cell cycle progression, proliferation, metabolism, adhesion, apoptosis, and therapeutic...